Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Nikcevich"'
Autor:
Jeremy T, Larsen, Tait D, Shanafelt, Jose F, Leis, Betsy, LaPlant, Tim, Call, Adam, Pettinger, Curtis, Hanson, Charles, Erlichman, Thomas Matthew, Habermann, Craig, Reeder, Daniel, Nikcevich, Deborah, Bowen, Michael, Conte, Justin, Boysen, Charla, Secreto, Connie, Lesnick, Renee, Tschumper, Diane, Jelinek, Neil E, Kay, Wei, Ding
Publikováno v:
American journal of hematology. 92(8)
Akt is a downstream target of B cell receptor signaling and is a central regulator of CLL cell survival. We aim to investigate the safety and efficacy of the Akt inhibitor MK-2206 in combination with bendamustine and rituximab (BR) in relapsed and/or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d20386fa0ece34de8a62127da146e1cd
https://pubmed.ncbi.nlm.nih.gov/28402581
https://pubmed.ncbi.nlm.nih.gov/28402581
Autor:
David P, Steensma, Shaker R, Dakhil, Paul J, Novotny, Jeff A, Sloan, David B, Johnson, Daniel M, Anderson, Bassam I, Mattar, Dennis F, Moore, Daniel, Nikcevich, Charles L, Loprinzi
Publikováno v:
American journal of hematology. 90(10)
Erythropoiesis-stimulating agents (ESAs) epoetin alfa (EA) and darbepoetin alfa (DA) increase hemoglobin (Hb) levels and reduce red blood cell (RBC) transfusion requirements in patients with cancer chemotherapy-associated anemia (CAA). Extended-inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4583f499a7a2b8c7009f2c6a0bb39445
https://pubmed.ncbi.nlm.nih.gov/26149465
https://pubmed.ncbi.nlm.nih.gov/26149465
Autor:
Wei Ding, Tait D Shanafelt, Clive S. Zent, Jose F. Leis, Betsy R. LaPlant, Timothy G. Call, Curtis A Hanson, Charles Erlichman, Thomas M. Habermann, Craig Reeder, Daniel Nikcevich, Deborah Bowen, Michael J. Conte, Justin Boysen, Charla Secreto, Connie Lesnick, Renee C. Tschumper, Diane F. Jelinek, Neil E. Kay
Publikováno v:
Blood. 122:2882-2882
Backgrounds B cell receptor (BCR) signals and microenvironment protection have been recognized to have key influences on CLL survival and activation. Akt activation is down-stream of the BCR signaling cascade and is critical in the mediation of the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63867dcf8ccb8a0fbec55e8999003f3a
https://doi.org/10.1182/blood.v122.21.2882.2882
https://doi.org/10.1182/blood.v122.21.2882.2882
Autor:
Jan Buckner, Joel Reid, Wenting Wu, Bernd Scheithauer, Matthew Ames, Sara Felten, Daniel Nikcevich, Martin Wiesenfeld, Kurt Jaeckle, Evanthia Galanis
Publikováno v:
Journal of Neuro-Oncology; Apr2009, Vol. 92 Issue 2, p165-175, 11p